News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
647,867 Results
Type
Article (61752)
Company Profile (70)
Press Release (586045)
Multimedia
Podcasts (60)
Webinars (13)
Section
Business (174551)
Career Advice (2735)
Deals (32529)
Drug Delivery (98)
Drug Development (77089)
Employer Resources (150)
FDA (14975)
Job Trends (13931)
News (306275)
Policy (29188)
Tag
Academia (2894)
Academic (2)
Accelerated approval (6)
Adcomms (22)
Allergies (88)
Alliances (43382)
ALS (88)
Alzheimer's disease (1322)
Antibody-drug conjugate (ADC) (111)
Approvals (14992)
Artificial intelligence (264)
Autoimmune disease (23)
Automation (15)
Bankruptcy (293)
Best Places to Work (10874)
BIOSECURE Act (16)
Biosimilars (101)
Biotechnology (53)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (275)
Cancer (2186)
Cardiovascular disease (166)
Career advice (2318)
Career pathing (33)
CAR-T (154)
Cell therapy (429)
Cervical cancer (20)
Clinical research (62683)
Collaboration (785)
Company closure (1)
Compensation (326)
Complete response letters (20)
COVID-19 (2577)
CRISPR (43)
C-suite (260)
Cystic fibrosis (101)
Data (2154)
Decentralized trials (2)
Denatured (25)
Depression (43)
Diabetes (252)
Diagnostics (6166)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (113)
Drug pricing (98)
Drug shortages (23)
Duchenne muscular dystrophy (86)
Earnings (60601)
Editorial (39)
Employer branding (18)
Employer resources (132)
Events (94871)
Executive appointments (760)
FDA (16231)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (749)
Gene editing (109)
Generative AI (20)
Gene therapy (299)
GLP-1 (669)
Government (4480)
Grass and pollen (6)
Guidances (64)
Healthcare (18271)
Huntington's disease (19)
IgA nephropathy (25)
Immunology and inflammation (109)
Indications (28)
Infectious disease (2712)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (96)
Interviews (526)
IPO (14820)
IRA (39)
Job creations (3443)
Job search strategy (1947)
Kidney cancer (10)
Labor market (30)
Layoffs (503)
Leadership (22)
Legal (6555)
Liver cancer (69)
Lung cancer (305)
Lymphoma (145)
Machine learning (7)
Management (53)
Manufacturing (276)
MASH (63)
Medical device (12673)
Medtech (12678)
Mergers & acquisitions (18286)
Metabolic disorders (633)
Multiple sclerosis (77)
NASH (13)
Neurodegenerative disease (84)
Neuropsychiatric disorders (26)
Neuroscience (1840)
NextGen: Class of 2025 (6396)
Non-profit (4336)
Now hiring (12)
Obesity (322)
Opinion (232)
Ovarian cancer (71)
Pain (91)
Pancreatic cancer (79)
Parkinson's disease (141)
Partnered (21)
Patents (236)
Patient recruitment (112)
Peanut (50)
People (59666)
Pharmaceutical (20)
Pharmacy benefit managers (15)
Phase I (19727)
Phase II (27658)
Phase III (20191)
Pipeline (1143)
Policy (127)
Postmarket research (2485)
Preclinical (8418)
Press Release (67)
Prostate cancer (107)
Psychedelics (27)
Radiopharmaceuticals (249)
Rare diseases (361)
Real estate (6007)
Recruiting (61)
Regulatory (20213)
Reports (33)
Research institute (2407)
Resumes & cover letters (405)
Rett syndrome (5)
RNA editing (3)
RSV (37)
Schizophrenia (68)
Series A (132)
Series B (86)
Service/supplier (9)
Sickle cell disease (51)
Special edition (10)
Spinal muscular atrophy (146)
Sponsored (29)
Startups (3350)
State (1)
Stomach cancer (9)
Supply chain (54)
Tariffs (26)
The Weekly (33)
Vaccines (669)
Venture capitalists (34)
Weight loss (202)
Women's health (30)
Worklife (19)
Date
Today (110)
Last 7 days (816)
Last 30 days (2460)
Last 365 days (30482)
2025 (10177)
2024 (32357)
2023 (36445)
2022 (46740)
2021 (51698)
2020 (50836)
2019 (44929)
2018 (34177)
2017 (30803)
2016 (30173)
2015 (35584)
2014 (28545)
2013 (25097)
2012 (26381)
2011 (26623)
2010 (25106)
Location
Africa (876)
Alabama (54)
Alaska (6)
Arizona (174)
Arkansas (14)
Asia (38134)
Australia (6858)
California (5559)
Canada (1904)
China (489)
Colorado (248)
Connecticut (260)
Delaware (141)
Europe (89079)
Florida (848)
Georgia (199)
Idaho (56)
Illinois (548)
India (25)
Indiana (279)
Iowa (10)
Japan (153)
Kansas (95)
Kentucky (24)
Louisiana (10)
Maine (61)
Maryland (831)
Massachusetts (4019)
Michigan (222)
Minnesota (338)
Mississippi (2)
Missouri (87)
Montana (29)
Nebraska (23)
Nevada (57)
New Hampshire (61)
New Jersey (1641)
New Mexico (29)
New York (1629)
North Carolina (957)
North Dakota (9)
Northern California (2408)
Ohio (194)
Oklahoma (15)
Oregon (36)
Pennsylvania (1238)
Puerto Rico (12)
Rhode Island (31)
South America (1179)
South Carolina (17)
South Dakota (1)
Southern California (2127)
Tennessee (95)
Texas (848)
United States (21266)
Utah (172)
Virginia (143)
Washington D.C. (51)
Washington State (516)
West Virginia (3)
Wisconsin (60)
647,867 Results for "university of british columbia".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medexus and British Columbia’s Provincial Health Services Authority (PHSA) Successfully Complete Agreement for Public Reimbursement of Trecondyv (treosulfan for injection) in British Columbia, Canada
January 15, 2025
·
8 min read
Policy
PreveCeutical Commences Litigation Against Former Legal Counsel in the British Columbia Supreme Court Alleging Professional Negligence
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”), announces that it, along with certain others, filed a Notice of Civil Claim (the “Claim”) in the British Columbia Supreme Court on June 5, 2024 against its former legal counsel (the “Defendants”).
June 6, 2024
·
5 min read
Press Releases
Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski
March 19, 2025
·
4 min read
Press Releases
Cagent Vascular Initiates Patient Enrollment in the Serranator® vs. POBA OCT Study at Columbia University Medical Center
April 10, 2025
·
2 min read
Cell MedX Corp. Announces Full Revocation of British Columbia Cease Trade Order
Cell MedX Corp. (“Cell MedX” or the “Company”) (OTC Pink: CMXC) announces that on November 22, 2023, the British Columbia Securities Commission
November 28, 2023
·
4 min read
Press Releases
Alaya.bio Expands in situ CAR-T Therapy Collaboration with Michel Sadelain and Columbia University
January 21, 2025
·
2 min read
Press Releases
Aspect Biosystems Announces $200 Million Partnership with the Governments of Canada and British Columbia to Advance Development of Bioprinted Tissue Therapeutics
July 23, 2024
·
3 min read
Press Releases
Vector Laboratories Announces Partnership With British Biotech Innovator Etcembly
February 20, 2025
·
3 min read
Andira Advances Lead Cannabinoid Compositions for Metastatic Breast Cancer through a Collaborative Research Agreement with Canada Research Chair in Oncology Dr. Karla Williams at the University of British Columbia
Andira Pharmaceuticals announces it will carry out pharmacologic characterization of its lead compounds for metastatic breast cancer through a collaborative research program with the University of British Columbia (UBC), Vancouver.
March 22, 2023
·
3 min read
Press Releases
TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha Inhibitor Isomyosamine at British Geriatrics Society’s Spring Meeting 2025
April 16, 2025
·
5 min read
1 of 64,787
Next
